EDITAS MEDICINE INC.
3.1800
07-11月-24 12:26:20
15 分の遅延
株式
-0.1000
-3.05%
本日の幅
3.1100 - 3.3000
ISIN
N/A
ソース
NASDAQ
-
Editas Medicine Announces First Quarter 2022 Results and Business Updates
04 5 2022 05:45:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2022 Results and Corporate Update
27 4 2022 05:55:00 提供 Nasdaq GlobeNewswire
-
26 4 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
Editas Medicine Appoints Gilmore O’Neill as Chief Executive Officer
14 4 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
11 4 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
08 4 2022 12:00:00 提供 Nasdaq GlobeNewswire
-
28 2 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates
24 2 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
16 2 2022 05:15:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference
10 1 2022 06:00:02 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 1 2022 05:58:00 提供 Nasdaq GlobeNewswire
-
20 12 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
12 11 2021 06:00:02 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces Third Quarter 2021 Results and Business Updates
08 11 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine Names Bernadette Connaughton to Board of Directors
28 10 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update
25 10 2021 15:01:00 提供 Nasdaq GlobeNewswire